Northeast Financial Consultants Inc - IMMUNOGEN INC ownership

IMMUNOGEN INC's ticker is IMGN and the CUSIP is 45253H101. A total of 207 filers reported holding IMMUNOGEN INC in Q1 2018. The put-call ratio across all filers is 3.66 and the average weighting 0.1%.

Quarter-by-quarter ownership
Northeast Financial Consultants Inc ownership history of IMMUNOGEN INC
ValueSharesWeighting
Q3 2022$164,000
+6.5%
34,3150.0%0.01%
+9.1%
Q2 2022$154,000
-5.5%
34,3150.0%0.01%
+22.2%
Q1 2022$163,000
-36.1%
34,3150.0%0.01%
-40.0%
Q4 2021$255,000
+30.8%
34,3150.0%0.02%
+15.4%
Q3 2021$195,000
-13.7%
34,3150.0%0.01%
-13.3%
Q2 2021$226,000
-18.7%
34,3150.0%0.02%
-28.6%
Q1 2021$278,000
+25.8%
34,3150.0%0.02%
+16.7%
Q4 2020$221,000
+78.2%
34,3150.0%0.02%
+63.6%
Q3 2020$124,000
-21.5%
34,3150.0%0.01%
-26.7%
Q2 2020$158,000
+35.0%
34,3150.0%0.02%
+15.4%
Q1 2020$117,000
-33.1%
34,3150.0%0.01%
-18.8%
Q4 2019$175,000
+110.8%
34,3150.0%0.02%
+100.0%
Q3 2019$83,000
+12.2%
34,3150.0%0.01%0.0%
Q2 2019$74,000
-20.4%
34,3150.0%0.01%
-20.0%
Q1 2019$93,000
-43.6%
34,3150.0%0.01%
-56.5%
Q4 2018$165,000
-50.5%
34,3150.0%0.02%
-77.7%
Q2 2018$333,000
-7.5%
34,3150.0%0.10%
-14.9%
Q1 2018$360,000
+64.4%
34,3150.0%0.12%
+65.8%
Q4 2017$219,000
-16.7%
34,3150.0%0.07%
-24.0%
Q3 2017$263,000
+7.8%
34,3150.0%0.10%0.0%
Q2 2017$244,000
+83.5%
34,3150.0%0.10%
+71.4%
Q1 2017$133,000
+90.0%
34,3150.0%0.06%
+80.6%
Q4 2016$70,000
-23.9%
34,3150.0%0.03%
-20.5%
Q3 2016$92,000
-13.2%
34,3150.0%0.04%
-17.0%
Q2 2016$106,000
-26.9%
34,315
+102.0%
0.05%
-38.2%
Q1 2016$145,000
-37.0%
16,9850.0%0.08%
-36.1%
Q4 2015$230,000
+41.1%
16,9850.0%0.12%
+43.4%
Q3 2015$163,000
-33.2%
16,9850.0%0.08%
-23.9%
Q2 2015$244,00016,9850.11%
Other shareholders
IMMUNOGEN INC shareholders Q1 2018
NameSharesValueWeighting ↓
SILVERARC CAPITAL MANAGEMENT, LLC 600,000$3,870,0002.25%
CM Management, LLC 375,000$2,419,0002.24%
Consonance Capital Management LP 3,515,944$22,678,0002.12%
RA Capital Management 18,417,458$118,793,0001.66%
Kercheville Advisors, LLC 244,421$1,564,0000.85%
Redmile Group, LLC 10,528,179$67,907,0000.82%
Birchview Capital, LP 190,000$1,226,0000.71%
QVT Financial LP 1,375,900$8,875,0000.49%
Fernwood Investment Management, LLC 149,340$963,0000.38%
TWIN FOCUS CAPITAL PARTNERS, LLC 104,068$671,0000.21%
View complete list of IMMUNOGEN INC shareholders